Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2023-08-18 Regulatory Filings
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
本公司腎臟新藥拿百磷接獲中國國家藥監局通知，正式受理 上市許可證之申請
Regulatory Filings Classification · 95% confidence The document is a short announcement (803 characters) from a listed company (寶齡富錦) reporting that their new kidney drug application for marketing approval has been formally accepted by the Chinese National Medical Products Administration (NMPA). It is a factual update about a regulatory milestone related to a product approval. There are no financial statements, no detailed financial data, no management discussion, no voting results, no meeting materials, and no mention of any report being attached or published. The document is a regulatory announcement about a material event affecting the company, fitting the category of a general regulatory filing. It is not a full report, nor a report publication announcement, nor a certification. Therefore, the best classification is Regulatory Filings (RNS).
2023-08-18 Chinese
本公司受邀參加凱基證券112年8月22日舉辦之法人說明會
Investor Presentation Classification · 95% confidence The document is a short announcement (677 characters) about the company 1760 寶齡富錦 being invited to participate in an investor presentation hosted by KGI Securities on August 22, 2023. It includes details such as date, time, location, and a brief description of the event focusing on the company's operational report and future outlook. There is no actual financial data or detailed report content included. The document serves as a notice of an upcoming investor presentation rather than the presentation itself or a financial report. According to the 'Menu vs Meal' rule, this is an announcement of a presentation event, fitting the category of Investor Presentation (IP). Given the short length and nature of the content, the classification is Investor Presentation (IP) with high confidence.
2023-08-16 Chinese
112年第2季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document contains detailed financial data related to investments in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. It references accounting standards and provides quantitative financial figures. The document length is 1246 characters, which is relatively short but contains substantive financial data rather than just an announcement or certification. The content aligns with a financial report for a specific period (112年2季, which corresponds to the second quarter of the year 112 in the Taiwanese calendar). This indicates it is a quarterly or interim financial report rather than an annual report or a simple announcement. Therefore, the most appropriate classification is Interim / Quarterly Report (IR).
2023-08-11 Chinese
112年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of the company's investments in mainland China, including capital amounts, investment methods, cumulative investment amounts, and recognized investment gains or losses. It includes notes explaining the investment methods, accounting bases for investment gains/losses, and regulatory limits on investments. The document is relatively short (1928 characters) and focuses on investment details rather than full financial statements or comprehensive reports. It does not present a full annual or interim report, nor is it an announcement of a meeting or voting results. The content aligns with regulatory disclosure requirements about overseas investments, which typically fall under general regulatory filings. There is no indication that this is a standalone audit report, earnings release, or capital update. Therefore, the best classification is Regulatory Filings (RNS).
2023-08-11 Chinese
112年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed tables of equity changes for the first half of the year 2023 (民國112年上半年度) and the same period in the previous year. It includes accounting items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented in a structured financial format with monetary units in thousands of New Taiwan Dollars. This type of detailed financial data on equity changes for a half-year period aligns with an Interim / Quarterly Report (IR), as it provides substantive financial data and analysis for a period shorter than a full fiscal year. The document length is 3622 characters, which is sufficient to contain actual financial data rather than just an announcement or certification. There is no indication that this is a full Annual Report (10-K) or just an announcement (RPA), nor is it a regulatory filing or certification. Therefore, the classification is Interim / Quarterly Report (IR).
2023-08-11 Chinese
112年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the fiscal year 112 (which corresponds to 2023 in the Taiwanese calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a period shorter than a full fiscal year (half-year or quarter) indicates this is a comprehensive interim or quarterly financial report. The document length is 2406 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-08-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.